Market Place
Sourcing Support
Bicycle Therapeutics Reports Q4 Progress and 2025 Guidance
17 Mar 2026 //
BUSSINESSWIRE
Bicycle Reveals Leadership Changes For Oncology Pipeline
03 Feb 2026 //
PHARMIWEB
Bicycle Forms Strategic Partnerships for End-to-End Supply Chain
16 Dec 2025 //
PHARMIWEB
Bicycle Therapeutics Boosts Board with New Appointments
08 Sep 2025 //
BUSINESSWIRE
Bicycle Cuts Staff as Genentech Ends R&D Pact
08 Aug 2025 //
FIERCE BIOTECH
Bicycle Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
02 Jul 2025 //
BUSINESSWIRE
Bicycle Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Jun 2025 //
BUSINESSWIRE
Bicycle Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
05 May 2025 //
BUSINESSWIRE
Bicycle Therapeutics Presents MT1-MMP Imaging Data at AACR 2025
29 Apr 2025 //
BUSINESSWIRE
Bicycle Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
05 Mar 2025 //
BUSINESSWIRE
Bicycle Therapeutics to Participate in Oppenheimer Conference
05 Feb 2025 //
BUSINESSWIRE
Bicycle Therapeutic Reports Inducement Grants Under Nasdaq LR 5635©
03 Feb 2025 //
BUSINESSWIRE
Bicycle Therapeutics Presents Data At Nuclear Medicine Congress
16 Oct 2024 //
BUSINESSWIRE
Bicycle Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
02 Oct 2024 //
BUSINESSWIRE
Bicycle Therapeutics Presents Updated Clinical Results At ESMO 2024
14 Sep 2024 //
BUSINESSWIRE
Bicycle Therapeutics Reports Inducement Grants Under NASDAQ Rule 5635(c)(4)
03 Sep 2024 //
BUSINESSWIRE
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
21 Aug 2024 //
BUSINESSWIRE
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024
06 Aug 2024 //
BUSINESSWIRE
Bicycle Therapeutics Reports Inducement Grants
01 Aug 2024 //
BUSINESSWIRE
Bicycle Therapeutics Announces Four Abstracts Accepted at the ESMO
22 Jul 2024 //
BUSINESSWIRE
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
03 Jun 2024 //
BUSINESSWIRE
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
23 May 2024 //
BUSINESSWIRE
Bicycle Btc® Phase 1/2 Pks: Safety At 2024 Asco Meeting
23 May 2024 //
BUSINESSWIRE
Bicycle’s $555M placement; Tango Therapeutics scraps cancer program
23 May 2024 //
ENDPTS
Bicycle Therapeutics Reports Recent Business Progress
02 May 2024 //
BUSINESSWIRE
Bicycle Presents Two Abstracts at ASCO 2024
24 Apr 2024 //
BUSINESSWIRE
Bicycle Thera to Participate in the 23rd Needham Virtual Healthcare Conference
02 Apr 2024 //
BUSINESSWIRE
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
05 Mar 2024 //
BUSINESSWIRE
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
28 Feb 2024 //
BUSINESSWIRE
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
20 Feb 2024 //
BUSINESSWIRE
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Conference
07 Feb 2024 //
BUSINESSWIRE
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs
14 Dec 2023 //
BUSINESSWIRE
Bicycle Therapeutics to Host R&D Day on December 14
30 Nov 2023 //
BUSINESSWIRE
Bicycle Therapeutics Reports Third Quarter 2023 Financial Results
02 Nov 2023 //
BUSINESSWIRE
Why Shares of Bicycle Therapeutics Were Rising on Monday
11 Sep 2023 //
FOOL
Bicycle Therapeutics to Participate in Morgan Stanley 21st Healthcare Conference
05 Sep 2023 //
BUSINESSWIRE
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results
03 Aug 2023 //
BUSINESSWIRE
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares
18 Jul 2023 //
BUSINESSWIRE
Why Bicycle Therapeutics Stock Raced Ahead Today
13 Jul 2023 //
FOOL
Bicycle Therapeutics to Present at 2023 AACR Annual Meeting
14 Apr 2023 //
PRESS RELEASE
Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting
14 Apr 2023 //
BUSINESSWIRE
Bicycle Therapeutics Enhances Leadership Team with Key Appointments
03 Apr 2023 //
BUSINESSWIRE
Novartis-Bicycle radiopharmaceuticals deal could cruise to $1.7B
29 Mar 2023 //
FIERCE BIOTECH
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
28 Feb 2023 //
BUSINESSWIRE
Bicycle to Participate in the SVB Securities Global Biopharma Conference
08 Feb 2023 //
BUSINESSWIRE
Bicycle to Present Posters Highlighting Data from Tumor- Immune Cell Agonist
11 Dec 2022 //
PRESS RELEASE
Bicycle to Present Highlighting Data from Tumor-Targeted Immune Cell Agonist
10 Nov 2022 //
PRESS RELEASE
Bicycle Therapeutics Announces First Patient Dosed in BT8009 Phase II
08 Nov 2022 //
PRESS RELEASE
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
04 Nov 2022 //
BUSINESSWIRE
Bicycle Therapeutics Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
BUSINESSWIRE
Bicycle Published in Journal of Medicinal Chemistry Highlighting BT8009 Program
10 Oct 2022 //
BUSINESSWIRE
Bicycle Health Announces $5 Million Investment From Cobalt Ventures to Scale
22 Sep 2022 //
GLOBENEWSWIRE
Bicycle Announces Publication of Article Highlighting Data from BT8009 Program
19 Sep 2022 //
BUSINESSWIRE
Bicycle Announces BT5528 Phase I Dose Escalation Results
07 Sep 2022 //
BUSINESSWIRE
Bicycle Therapeutics to Participate in the Morgan Stanley Healthcare Conference
06 Sep 2022 //
BUSINESSWIRE
Bicycle Therapeutics Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
BUSINESSWIRE
Bicycle Tx to Publish Article in Bioconjugate Chemistry on Bicyclic Peptides
02 Aug 2022 //
BUSINESSWIRE
Genentech rides up to 2nd oncology target in Bicycle collab
13 Jul 2022 //
FIERCEBIOTECH
Bicycle to Publish Article Highlighting Preclinical Data from BT7480 Program
12 Jul 2022 //
BUSINESSWIRE
Bicycle Tx Begins Dosing in Expansion Cohorts of PI/II Trial of BT5528
08 Jun 2022 //
BUSINESSWIRE
